Covid 19 Vaccine Study
- All
- News
- Web Stories
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Rapid Testing In Kids To Catching Covid Via Breastmilk: What Studies Say
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
-
Covid Variants Getting Better At Travelling Through Air, Study Shows
The variants of S-CoV-2 are getting better at travelling through the air, and people must wear tight-fitting masks, ensure better ventilation, get vaccinated, to help stop spread of the virus that causes Covid, according to a study.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
6 Months' Immunity In Mild Covid Patients As Antibodies Persist: Study
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
In Bid To Increase Coverage, Thailand To Explore Injecting Covid Vaccines Under Skin
Thailand is studying the possibility of injecting coronavirus vaccines under the skin to try to stretch its limited supply, a health official said on Thursday, as the country races to inoculate the public faster amid a worsening epidemic.
-
Delta Gives Vaccinated People Same Virus Amount As Unvaccinated: Study
Vaccines against Covid-19 are less effective against the delta variant, a large U.K. study showed in results that may fuel a push for booster shots for fully vaccinated people.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Covishield-Covaxin Mix Gives Results, Says Medical Body, Seeks More Study
The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the COVID-19 vaccination programme, conducted on 18 people, has elicited better safety results.
-
Risk Of Vaccine-Resistant Variants Increases With Vaccine Coverage? Study Answers
Relaxing restrictions like mask-wearing and social distancing when most people have been vaccinated greatly increases the risk of vaccine-resistant variants of the virus that causes Covid-19, new research showed on Friday.
-
Pfizer Shot 97% Effective Against Symptomatic Covid: Study
Pfizer/BioNTech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies.
-
YouTube to Add Link on COVID-19 Vaccines to Combat Misinformation
YouTube said it is adding a link to provide information on the development of COVID-19 vaccines to the coronavirus panel on its site, expanding its efforts to combat misinformation related to the pandemic.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Rapid Testing In Kids To Catching Covid Via Breastmilk: What Studies Say
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
-
Covid Variants Getting Better At Travelling Through Air, Study Shows
The variants of S-CoV-2 are getting better at travelling through the air, and people must wear tight-fitting masks, ensure better ventilation, get vaccinated, to help stop spread of the virus that causes Covid, according to a study.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
6 Months' Immunity In Mild Covid Patients As Antibodies Persist: Study
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
In Bid To Increase Coverage, Thailand To Explore Injecting Covid Vaccines Under Skin
Thailand is studying the possibility of injecting coronavirus vaccines under the skin to try to stretch its limited supply, a health official said on Thursday, as the country races to inoculate the public faster amid a worsening epidemic.
-
Delta Gives Vaccinated People Same Virus Amount As Unvaccinated: Study
Vaccines against Covid-19 are less effective against the delta variant, a large U.K. study showed in results that may fuel a push for booster shots for fully vaccinated people.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Covishield-Covaxin Mix Gives Results, Says Medical Body, Seeks More Study
The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the COVID-19 vaccination programme, conducted on 18 people, has elicited better safety results.
-
Risk Of Vaccine-Resistant Variants Increases With Vaccine Coverage? Study Answers
Relaxing restrictions like mask-wearing and social distancing when most people have been vaccinated greatly increases the risk of vaccine-resistant variants of the virus that causes Covid-19, new research showed on Friday.
-
Pfizer Shot 97% Effective Against Symptomatic Covid: Study
Pfizer/BioNTech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies.
-
YouTube to Add Link on COVID-19 Vaccines to Combat Misinformation
YouTube said it is adding a link to provide information on the development of COVID-19 vaccines to the coronavirus panel on its site, expanding its efforts to combat misinformation related to the pandemic.
